Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant
2011
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
2016
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Plea for routinely presenting prediction intervals in meta-analysis
2016 Standout
A Converse 4-1BB and CD40 Ligand Expression Pattern Delineates Activated Regulatory T Cells (Treg) and Conventional T Cells Enabling Direct Isolation of Alloantigen-Reactive Natural Foxp3+ Treg
2012
Introduction, comparison, and validation of Meta‐Essentials : A free and simple tool for meta‐analysis
2017 Standout
Regulatory T cells in autoimmune kidney diseases and transplantation
2023 StandoutNobel
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation
2012
Learning the Dynamic Treatment Regimes from Medical Registry Data through Deep Q-network
2019
International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: Proposed Diagnostic Criteria for Chronic GVHD (Part I)
2013
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Mapping and Quantification of Over 2000 O-linked Glycopeptides in Activated Human T Cells with Isotope-Targeted Glycoproteomics (Isotag)
2018 StandoutNobel
Cancer treatment and survivorship statistics, 2022
2022 Standout
Control of Regulatory T Cells by Co-signal Molecules
2019 StandoutNobel
PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy
2017
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
2014 Standout
O-GlcNAc signaling: a metabolic link between diabetes and cancer?
2010
Correlation Between Tear Film Osmolarity and the Disease Score of the International Chronic Ocular Graft-Versus-Host-Disease Consensus Group in Hematopoietic Stem Cell Transplantation Patients
2015
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Breast cancer
2016 Standout
The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method
2014
Ocular manifestations of graft-versus-host disease
2013
Ocular Graft-versus-Host Disease: A Review
2013
A Chemical Glycoproteomics Platform Reveals O-GlcNAcylation of Mitochondrial Voltage-Dependent Anion Channel 2
2013 StandoutNobel
Graft versus host disease: clinical evaluation, diagnosis and management
2013
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart–lung transplantation Report—2019; Focus theme: Donor and recipient size match
2019 Standout
The Binary Classification of Protein Kinases
2021
Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria
2012
Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia
2010
Neutrophils Exhibit Rapid Agonist-induced Increases in Protein-associated O-GlcNAc
2004
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
TFOS DEWS II Diagnostic Methodology report
2017 Standout
O‐GlcNAcase is essential for embryonic development and maintenance of genomic stability
2012
Isotope-targeted glycoproteomics (IsoTaG): a mass-independent platform for intact N- and O-glycopeptide discovery and analysis
2015 StandoutNobel
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
2019 Standout
Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis
2016 Standout
TFOS DEWS II pathophysiology report
2017 Standout
European cancer mortality predictions for the year 2016 with focus on leukaemias
2016
Cell signaling, the essential role of O-GlcNAc!
2006
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
TFOS DEWS II Epidemiology Report
2017 Standout
Gene Therapy With Regulatory T Cells: A Beneficial Alliance
2018
Coordination of COPII vesicle trafficking by Sec23
2008 StandoutNobel
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Dynamic interplay between O-GlcNAc and O-phosphate: the sweet side of protein regulation
2003
Foxp3: a genetic foundation for regulatory T cell differentiation and function
2020 StandoutNobel
Transplant trials with Tregs: perils and promises
2017
Tear Cytokines as Biomarkers for Chronic Graft-versus-Host Disease
2015
Perturbations in O-linked β-N-Acetylglucosamine Protein Modification Cause Severe Defects in Mitotic Progression and Cytokinesis
2005
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
A Single-Center Pilot Prospective Study of Topical Application of Platelet-Derived Eye Drops for Patients with Ocular Chronic Graft-versus-Host Disease
2016
TFOS DEWS II Management and Therapy Report
2017 Standout
T cells expressing chimeric antigen receptor promote immune tolerance
2017
Extracorporeal Photopheresis in Steroid-Refractory Acute or Chronic Graft-versus-Host Disease: Results of a Systematic Review of Prospective Studies
2014
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
Chemistry in living systems
2005 StandoutNobel
A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells
2016 StandoutNobel
Tocilizumab for the Treatment of Steroid Refractory Graft-versus-Host Disease
2011
TREG-cell therapies for autoimmune rheumatic diseases
2014 StandoutNobel
Symptoms and Quality of Life in Diverse Patients Undergoing Hematopoietic Stem Cell Transplantation
2012
Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis
2015
Meta-analysis in clinical trials revisited
2015 Standout
New Treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression
2020 StandoutNobel
The Transcription Factor Mef2 Links the Drosophila Core Clock to Fas2, Neuronal Morphology, and Circadian Behavior
2013 StandoutNobel
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
2011
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontier
2018
Treg cell-based therapies: challenges and perspectives
2019
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Metabolic cross-talk allows labeling of O-linked β- N -acetylglucosamine-modified proteins via the N -acetylgalactosamine salvage pathway
2011 StandoutNobel
Survival of some photoreceptor cells in albino rats following long-term exposure to continuous light.
1976
Unique properties of thymic antigen-presenting cells promote epigenetic imprinting of alloantigen-specific regulatory T cells
2017 StandoutNobel
Regulatory T Cells and Human Disease
2020 StandoutNobel
Acute Myeloid Leukemia
2015 Standout
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Biomarkers in Ocular Chronic Graft Versus Host Disease: Tear Cytokine- and Chemokine-Based Predictive Model
2016
Current approaches to prevent and treat GVHD after allogeneic stem cell transplantation
2018
Gene Expression–Based Predictive Models of Graft Versus Host Disease–Associated Dry Eye
2015
A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease
2020
Review on deep learning applications in frequency analysis and control of modern power system
2021 Standout
Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysis
2014
Alloreactive regulatory T cells generated with retinoic acid prevent skin allograft rejection
2014
Transplantation-Associated Thrombotic Microangiopathy in Patients Treated With Sirolimus and Cyclosporine as Salvage Therapy for Graft-Versus-Host Disease
2015
Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial
2020
Current issues in chronic graft-versus-host disease
2014
Cancer treatment and survivorship statistics, 2019
2019 Standout
Post-Transplantation Lymphoproliferative Disorders in Adults
2018
Microglial M1/M2 polarization and metabolic states
2015 Standout
Chemical Modulation of Protein O-GlcNAcylation via OGT Inhibition Promotes Human Neural Cell Differentiation
2017 StandoutNobel
High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis
2013
Regulatory T cells expressing abundant CTLA‐4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer
2018 StandoutNobel
Studies of visual function and its decay in mice with hereditary retinal degeneration
1978 StandoutNobel
Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
2020 StandoutNobel
Classification systems for chronic graft-versus-host disease
2016
The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society
2017
Works of Joseph Pidala being referenced
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: III. The 2014 Biomarker Working Group Report
2015
Pulmonary Symptoms Measured by the National Institutes of Health Lung Score Predict Overall Survival, Nonrelapse Mortality, and Patient-Reported Outcomes In Chronic Graft-Versus-Host Disease
2013
Analysis of Gastrointestinal and Hepatic Chronic Grant-versus-Host Disease Manifestations on Major Outcomes: A Chronic Grant-versus-Host Disease Consortium Study
2013
Sirolimus as Primary Treatment of Acute Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation
2009
ATG Prevents Severe Acute Graft-versus-Host Disease in Mismatched Unrelated Donor Hematopoietic Cell Transplantation
2011
Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report
2015
Increased N-acetyl-β-glucosaminidase activity in primary breast carcinomas corresponds to a decrease in N-acetylglucosamine containing proteins
2001
Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study
2011
Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD
2014
Glucocorticoid-Refractory Acute Graft-versus-Host Disease
2010
Clinical Benefit of Response in Chronic Graft-versus-Host Disease
2012
The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality
2011
Infliximab for Managing Steroid-Refractory Acute Graft-versus-Host Disease
2009
Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
2009
Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice
2015
Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
2015
Validation of Measurement Scales in Ocular Graft-versus-Host Disease
2011
Poor Agreement between Clinician Response Ratings and Calculated Response Measures in Patients with Chronic Graft-versus-Host Disease
2012
Assessment of Joint and Fascia Manifestations in Chronic Graft‐Versus‐Host Disease
2013
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report
2015
Mycophenolate mofetil for the management of steroid-refractory acute graft vs host disease
2009
Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium
2011
Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium
2013
Biologic markers of chronic GVHD
2013
Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation
2015
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation
2012
Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoids
2011
Decision Analysis of Peripheral Blood versus Bone Marrow Hematopoietic Stem Cells for Allogeneic Hematopoietic Cell Transplantation
2009
HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research
2015
Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease
2014
Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission
2013
Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission
2011
The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors
2013
Tools for the Precision Medicine Era: How to Develop Highly Personalized Treatment Recommendations From Cohort and Registry Data Using Q-Learning
2017
Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease
2013
Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria
2011
Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining T reg and antitumor CTL function
2017
Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly
2011
Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease
2015
Pentostatin as rescue therapy for glucocorticoid-refractory acute and chronic graft-versus-host disease.
2011
Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation
2018
Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium
2011
Quality of life after allogeneic hematopoietic cell transplantation
2009
Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium
2012